The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Shai Mulinari has published three journal articles on drugs and public health

Published 3 July 2015

The articles concern first the Zelmid case, the first SSRI antidepressant in the journal Social Science & Medicine, second the use of broad migrant categories and third the question if maternal country of birth can be used to understand birthweight.

Divergence and convergence of commercial and scientific priorities in drug development: the case of Zelmid, the first SSRI antidepressant in Social Science & Medicine. 

Learn more at sciencedirect.com

 

Questioning the discriminatory accuracy of broad migrant categories in public health: self-rated health in Sweden, together with Anna Bredström and Juan Merlo in European Journal of Public Health. 

Learn more at oxfordjournals.org

 

Does Maternal Country of Birth Matter for Understanding Offspring’s Birthweight? A Multilevel Analysis of Individual Heterogeneity in Sweden

Learn more at plosone.org

 

Go to Shai Mulinari's personal page

Latest news

Link to rss
All news
17 Nov 2020